Biotech CEO Sisterhood: Daré Bioscience's Founder & CEO Sabrina Johnson describes her company's mission to make women's health a priority
Interviewed by Sisterhood editorial board member Grace Colón, she describes the unmet need for developing evidence based products for women's heath, and women's sexual health specifically. Plus, how Daré has thought outside the box regarding its path to market, including utilizing compounding, her experience running a public company, thoughts on mitigating potential FDA delays, and advice for entrepreneurs.
--------
29:59
Biotech CEO Sisterhood: Named CEO of Acadia Pharmaceuticals in September, Catherine Owen Adams describes taking the leap from a career in 'pharma' to running an independent, commercial stage biotech
Interviewed by Sisterhood editorial board member Julia Owens, Catherine Owen Adams shares her career journey, and discusses the perceived and real differences between pharma and biotech. She introduces us to Acadia Pharmaceuticals and talks about what it has been like in the job so far.
--------
23:16
X4 Pharmaceuticals' CEO Paula Ragan on her career and running a commercial stage company in the rare disease space
Interviewed by Sisterhood editorial board member Erika Smith, Paula Ragan shares her career path and things she has learned along the way. She describes what it is like managing a company during these volatile times for the sector, and previews a big readout X4 will have next year.
--------
16:17
Biotech CEO Sisterhood: Gallop Oncology CEO Luba Greenwood on the importance of the Sisterhood, the Massachusetts life sciences ecosystem, and Gallop's work
Interviewed by Normunity CEO Rachel Humphrey at MassBio's 2025 State of Possible Conference, Luba explains how the Sisterhood arms members with important information, she shares the impression of the Massachusetts ecosystem she has gained as a MassBio board member, and also describes the effort against cancer at Gallop that motivates her each day.
--------
16:30
Alnylam CEO Yvonne Greenstreet on her career path, the importance of diversity of opinions, and leading Alnlyam into a critical phase of growth
Interviewed by Sisterhood editorial board member Sheila Gujrathi, Yvonne Greenstreet describes her upbringing and early career as a physician in the UK, her decision to get an MBA, and the mentors who have impacted her path. She describes joining Alnylam in 2016, and the growth that has happened there since then. Plus, how being CEO has been different, and the values she prioritizes as a leader.
Members of the Biotech CEO Sisterhood regularly interview women leaders in biotech about news, science, management topics and more. Tune in to hear from top leaders in biotech about topics that matter to the industry.
New Zealand